Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons
- 1 June 1987
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 10 (3) , 241-246
- https://doi.org/10.1007/bf03348122
Abstract
Reportedly, most acromegalics are refractory to the growth hormone (GH)-releasing effect of central nervous system-acting stimuli. For instance, the synthetic analogue of met-enkephalin (Enk) viz. FK 33-824 fails to alter the high circulating GH levels of acromegalics. The most likely interpretation of such finding is that circulating GH disrupts, for a negative feedback effect, hypothalamic opioid function and/or GH-releasing hormone (GHRH) producing neurons, through which opioids exert their action. To address this issue, we have evaluated in intact and hypophysectomized male rats the effect of a high-dose GH regimen on the hypothalamic stores of endogenous opioid peptides, β-endorphin (β-EP) and met-enkephalin (met-enk). Moreover we have evaluated in intact male rats the effect of exogenous GH on median eminence (ME) GHRH stores and the ability of FK 33-824 to stimulate GH and prolactin (PRL) secretion and of exogenous GHRH to induce GH secretion. Human GH (25 and 250 μg bid for 4 days) administered to hypophysectomized rats strikingly reduced β-EP and met-enk-like immunoreactivity (LI) in the medial basal hypothalamus, the effect being already maximal with the lower hGH dose. The higher dose of hGH diminished, though to a lower extent, hypothalamic βEP-LI content also in intact rats, and reduced GHRH-LI content in the ME. Despite these profound biochemical alterations, the GH responsiveness to GHRH and FK 33-824 administration was preserved, while the latter drug induced a lower PRL rise in GH-treated than in control rats. These results indicate that a) administration of GH alters profoundly hypothalamic concentrations of opioid peptides and GHRH but adaptive changes intervene in the neuroendocrine mechanisms for GH control; 2) similar biochemical alterations are likely occurring in the hypothalamus of some acromegalics, however, 3) in the latter, sustained elevations in circulating GH levels would finally result in disruption of the GHRH synthesizing neurons.Keywords
This publication has 24 references indexed in Scilit:
- On the Mechanism of Growth Hormone Autofeedback Regulation: Possible Role of Somatostatin and Growth Hormone-Releasing Factor*Endocrinology, 1985
- Modulation of Somatostatin Binding To Rat Pituitary Membranes by Exogenously Administered Growth Hormone*Endocrinology, 1985
- Hypothalamic neurotransmitter function in experimentally induced hyperprolactinemiaBrain Research, 1984
- ANTIBODIES TO GROWTH HORMONE-RELEASING FACTOR INHIBIT SOMATIC GROWTH.Endocrinology, 1984
- Prolonged Hyperprolactinemia Influencesβ-Endorphin and Met-Enkephalin in the Brain*Endocrinology, 1980
- β-Endorphin-Induced Decrease in Hypothalamic Dopamine Turnover*Endocrinology, 1980
- Acromegaly Associated with a Bronchial Carcinoid Tumor: Evidence for Ectopic Production of Growth Hormone-Releasing Activity*Journal of Clinical Endocrinology & Metabolism, 1979
- Supersensitivity to opioids following the chronic blockade of endorphin action by naloxoneNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Selective Actions of Prolactin on Catecholamine Turnover in the Hypothalamus and on Serum LH and FSHNeuroendocrinology, 1976
- Catecholamines in the Median Eminence: New Evidence for a Major Noradrenergic InputNature, 1973